GeneExcel

About:

GeneExcel is engaged in the R&D and deployment of liposome technologies for the treatment of cancer, HIV, and cardiovascular diseases.

Top Investors: ITX International Holdings

Description:

GeneExcel engages in the discovery, design, development, and deployment of liposome technologies. Its technologies are utilized for the treatment of cancer, cardiovascular diseases, and HIV-1-related diseases. The company also provides contract manufacturing services for customized systemic liposome products. Gene Excel was founded in 2002 and is based in Houston, Texas.